Related Experiment Video
Updated: May 15, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
A case report of anti-AMPAR encephalitis with involuntary limb shaking and aphasia
Shuang Li1,2, Tiantian Huo2, Minxia Geng2,3
1Graduate School of Hebei North University, Zhangjiakou, Hebei, China.
Rationale:
Anti-alpha-amino-3-hydroxy-5-methyl-4-isozolipropionic acid receptor (AMPAR) encephalitis is a rare autoimmune encephalitis mediated by anti-AMPAR antibodies produced on the surface of neuronal cells. Anti-AMPAR encephalitis has a variety of clinical manifestations, the common clinical manifestations are characterized by borderline encephalitis, including short-term memory loss, confusion, behavioral abnormalities, and seizures.
Patient Concerns:
Here we report a case of anti-AMPAR encephalitis in an adolescent female with aphasia as the first symptom of involuntary limb shaking.
Diagnoses:
The diagnosis of anti-AMPAR encephalitis is based on clinical symptoms and further detection of serum antibodies.
Interventions And Outcomes:
The patient responded well to intravenous methylprednisolone combined with immunoglobulin treatment, and her limbs no longer shook and her speech was fluent.
Lessons:
Early diagnosis of autoimmune encephalitis is challenging due to the heterogeneity of clinical manifestations. Our patient was initially diagnosed with involuntary limb movement, so we should conduct further research on symptoms associated with autoimmune encephalitis.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Parkinson's Disease: Overview

